4//SEC Filing
Moore Yan 4
Accession 0000899243-23-006729
CIK 0001850838other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:05 PM ET
Size
5.5 KB
Accession
0000899243-23-006729
Insider Transaction Report
Form 4
Moore Yan
Chief Medical Officer
Transactions
- Award
Option (Right to Buy)
2023-02-28+55,000→ 55,000 totalExercise: $6.46Exp: 2033-02-27→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable with respect to 25% of the underlying shares on February 28, 2024 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 28, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0001901999
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:05 PM ET
- Size
- 5.5 KB